Related Experiment Video

Updated: Jul 17, 2026

Nerve Stem Cell Differentiation by a One-step Cold Atmospheric Plasma Treatment In Vitro
07:01

Nerve Stem Cell Differentiation by a One-step Cold Atmospheric Plasma Treatment In Vitro

Published on: January 11, 2019

Scalp cooling therapy and cytotoxic treatment

S A Forsberg

    Lancet (London, England)
    |April 17, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Evaluation of the Impact of a New Cooling Cell Processor System on Islet Cell Isolation Facility
    05:21

    Evaluation of the Impact of a New Cooling Cell Processor System on Islet Cell Isolation Facility

    Published on: August 11, 2023

    A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
    07:22

    A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

    Published on: March 14, 2025

    Related Experiment Videos

    Last Updated: Jul 17, 2026

    Nerve Stem Cell Differentiation by a One-step Cold Atmospheric Plasma Treatment In Vitro
    07:01

    Nerve Stem Cell Differentiation by a One-step Cold Atmospheric Plasma Treatment In Vitro

    Published on: January 11, 2019

    Evaluation of the Impact of a New Cooling Cell Processor System on Islet Cell Isolation Facility
    05:21

    Evaluation of the Impact of a New Cooling Cell Processor System on Islet Cell Isolation Facility

    Published on: August 11, 2023

    A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
    07:22

    A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

    Published on: March 14, 2025

    Related Concept Videos

    Responses to Heat and Cold Stress02:45

    Responses to Heat and Cold Stress

    Every organism has an optimum temperature range within which healthy growth and physiological functioning can occur. At the ends of this range, there will be a minimum and maximum temperature that interrupt biological processes.
    Methods of reducing fever01:22

    Methods of reducing fever

    The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
    Pharmacological Methods of Reducing Fever:
    Physical Methods for Controlling Microbial Growth: Temperature01:23

    Physical Methods for Controlling Microbial Growth: Temperature

    Heat is a widely used method to control microbial growth by targeting and denaturing cellular proteins, thereby killing or inactivating microbes. This method's effectiveness is quantified using parameters such as the thermal death point (TDP), thermal death time (TDT), and decimal reduction time (D value). TDP represents the lowest temperature at which all microorganisms in a liquid suspension are eliminated within 10 minutes, whereas TDT is the time necessary to achieve sterilization at a...

    Articles linked to this work by shared authors, journal, and citation graph.

    Infant metabolic screening: a total quality management approach.

    Journal of obstetric, gynecologic, and neonatal nursing : JOGNN·1997

    Coronary arteriography in 486 patients--arteriographic pathology and prognosis.

    Acta medica Scandinavica·1979

    Myocardial infarction complicated by heart block--treatment and long-term prognosis.

    Acta medica Scandinavica·1979

    Quantitation of the gain in mortality in life-time after pacemaker treatment.

    Acta medica Scandinavica·1978

    Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

    Lancet (London, England)·2026

    Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

    Lancet (London, England)·2026

    Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

    Lancet (London, England)·2026

    [177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

    Lancet (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us